Chronix Biomedical Raises $2.8M

Wade Roush3/14/11

San Jose, CA-based Chronix Biomedical, a developer of tests that can detect cancer and neurologic diseases from DNA circulating in the blood, has raised $2.8 million in a sale of equity and options, according to a regulatory filing. The round’s 11 investors are not identified, but the company’s previous backers include Prairie Gold Venture Partners in Sioux Falls, SD.

Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @